(Q38958563)

8 September 2017

1 reference

title

Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape (English)

1 reference

8 September 2017

1

Malte Mohme

1 reference

8 September 2017

2

Sabine Riethdorf

1 reference

8 September 2017

Klaus Pantel

3

1 reference

PubMed ID

27644321

8 September 2017

language of work or name

English

0 references

publication date

20 September 2016

1 reference

Nature Reviews Clinical Oncology

8 September 2017

1 reference

8 September 2017

14

1 reference

8 September 2017

3

1 reference

8 September 2017

155-167

1 reference

https://scigraph.springernature.com/pub.10.1038/nrclinonc.2016.144

8 September 2017

0 references

cites work

Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

A pooled analysis of bone marrow micrometastasis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Meta-analysis of the prognostic value of circulating tumor cells in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Chemotherapy of WAP-T mouse mammary carcinomas aggravates tumor phenotype and enhances tumor cell dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Bone marrow as a reservoir for disseminated tumor cells: a special source for liquid biopsy in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Detection, clinical relevance and specific biological properties of disseminating tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Circulating and disseminated tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Tumor self-seeding by circulating cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Immune infiltration in human tumors: a prognostic factor that should not be ignored

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

T cell exclusion, immune privilege, and the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Hematogenous dissemination of glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Detection of brain tumor cells in the peripheral blood by a telomerase promoter-based assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Brain tumor cells in circulation are enriched for mesenchymal gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

An individual patient data meta-analysis on characteristics, treatments and outcomes of glioblastoma/ gliosarcoma patients with metastases outside of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

The three Es of cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Does the immune system naturally protect against cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Adaptive immunity maintains occult cancer in an equilibrium state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Immune-mediated dormancy: an equilibrium with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Interferons, immunity and cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Adaptive Immune Resistance: How Cancer Protects from Immune Attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Suppression, subversion and escape: the role of regulatory T cells in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

T-regulatory cells: key players in tumor immune escape and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

The biology of innate lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

NK cells and cancer immunosurveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Circulating tumor cells (CTCs) from metastatic breast cancer patients linked to decreased immune function and response to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Comparative analysis of innate immune system function in metastatic breast, colorectal, and prostate cancer patients with circulating tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Tumor induced inactivation of natural killer cell cytotoxic function; implication in growth, expansion and differentiation of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Toll-like receptor (TLR) expression of immune system cells from metastatic breast cancer patients with circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

TLR activation of tumor-associated macrophages from ovarian cancer patients triggers cytolytic activity of NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Role of natural killer cells in control of cancer metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Perforin-dependent direct cytotoxicity in natural killer cells induces considerable knockdown of spontaneous lung metastases and computer modelling-proven tumor cell dormancy in a HT29 human colon cancer xenograft mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

TRAIL-coated leukocytes that kill cancer cells in the circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Macrophages eliminate circulating tumor cells after monoclonal antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Macrophages in the liver prevent metastasis by efficiently eliminating circulating tumor cells after monoclonal antibody immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Capture of viable circulating tumor cells in the liver of colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

The multifaceted role of the microenvironment in liver metastasis: biology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Prognostic and predictive impact of intra- and peritumoral immune infiltrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Circulating Tumor Cells (CTC) Are Associated with Defects in Adaptive Immunity in Patients with Inflammatory Breast Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Contribution of platelets to tumour metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Metastasis: new functional implications of platelets and megakaryocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Cytokeratin 8-MHC class I interactions: a potential novel immune escape phenotype by a lymph node metastatic carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

NKG2D ligands in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Hypoxia induces escape from innate immunity in cancer cells via increased expression of ADAM10: role of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Role of non-classical MHC class I molecules in cancer immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

The Fas/Fas-ligand system: a mechanism for immune evasion in human breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

The role of Fas/FasL in the metastatic potential of osteosarcoma and targeting this pathway for the treatment of osteosarcoma lung metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Fas and Fas ligand interactions suppress melanoma lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Autocrine secretion of Fas ligand shields tumor cells from Fas-mediated killing by cytotoxic lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Tumor-driven evolution of immunosuppressive networks during malignant progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Immune escape and survival mechanisms in circulating tumor cells of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Co-expression of MET and CD47 is a novel prognosticator for survival of luminal breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Crosstalk between CTC, Immune System and Hypoxic Tumor Microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

The interrelating dynamics of hypoxic tumor microenvironments and cancer cell phenotypes in cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Disseminated Tumor Cells Persist in the Bone Marrow of Breast Cancer Patients through Sustained Activation of the Unfolded Protein Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Chimeric antigen receptor therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

The future of immune checkpoint therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

The blockade of immune checkpoints in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Inhibitory B7-family molecules in the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Biology, detection, and clinical implications of circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: significance in claudin-low breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

PD-L1 induces epithelial-to-mesenchymal transition via activating SREBP-1c in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

CD44+ Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell-Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

CXCR4-SDF-1 interaction potentially mediates trafficking of circulating tumor cells in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Frequent expression of PD-L1 on circulating breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

PD-L1 expression by circulating breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Gene expression patterns through oral squamous cell carcinoma development: PD-L1 expression in primary tumor and circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Natural mechanisms protecting against cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

The metastasis-promoting roles of tumor-associated immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Immune cell promotion of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Elevated chronic inflammatory factors and myeloid-derived suppressor cells indicate poor prognosis in advanced melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Resistance to apoptosis and expansion of regulatory T cells in relation to the detection of circulating tumor cells in patients with metastatic epithelial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Gene expression profiling of circulating tumor cells and peripheral blood mononuclear cells from breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

PARP-1 controls immunosuppressive function of regulatory T cells by destabilizing Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Allergic pulmonary inflammation promotes the recruitment of circulating tumor cells to the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Interleukin-17A modulates circulating tumor cells in tumor draining vein of colorectal cancers and affects metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

NF-kappaB activation within macrophages leads to an anti-tumor phenotype in a mammary tumor lung metastasis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

CD44 and HCELL: preventing hematogenous metastasis at step 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Circulating tumor cells from prostate cancer patients interact with E-selectin under physiologic blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Neutrophils promote liver metastasis via Mac-1-mediated interactions with circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Neutrophil granulocytes promote the migratory activity of MDA-MB-468 human breast carcinoma cells via ICAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Neutrophil Extracellular Traps Accumulate in Peripheral Blood Vessels and Compromise Organ Function in Tumor-Bearing Animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Establishment and characterization of a cell line from human circulating colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Detection of mutations in EGFR in circulating lung-cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

The two faces of interferon-γ in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Tumour exosome integrins determine organotropic metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Cancer genetics: the origin and evolution of an ancient cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Role of altered expression of HLA class I molecules in cancer progression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Metastatic consequences of immune escape from NK cell cytotoxicity by human breast cancer stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

HLA-G expression in cancers: roles in immune evasion, metastasis and target for therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Predictive value of HLA-G and HLA-E in the prognosis of colorectal cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

In vivo evidence that secretion of HLA-G by immunogenic tumor cells allows their evasion from immunosurveillance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Predominant expression of Fas (CD95) ligand in metastatic melanoma revealed by longitudinal analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Fas ligand expression is correlated with metastasis in colorectal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Programmed cell removal: a new obstacle in the road to developing cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Variant isoforms of CD44 are P- and L-selectin ligands on colon carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Monitoring circulating tumor cells in cancer vaccine trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Quantification and phenotypic characterization of circulating tumor cells for monitoring response to a preventive HER2/neu vaccine-based immunotherapy for breast cancer: a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2016.144

Fas and Fas ligand interactions in malignant disease

31 March 2020

1 reference

12 December 2020

Down-regulation of CD28, TCR-zeta (zeta) and up-regulation of FAS in peripheral cytotoxic T-cells of primary breast cancer patients.

1 reference

12 December 2020

Tumor cell dissemination patterns and metastasis of murine mammary carcinoma

1 reference

12 December 2020

Melanoma cell extravasation under flow conditions is modulated by leukocytes and endogenously produced interleukin 8.

1 reference

12 December 2020

Polymorphonuclear leukocytes increase the adhesion of circulating tumor cells to microvascular endothelium

1 reference

12 December 2020

Relationship between circulating tumor cells and peripheral T-cells in patients with primary breast cancer

1 reference

12 December 2020

The concept of immunological surveillance

1 reference

12 December 2020

PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma

1 reference

12 December 2020

Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells

1 reference

12 December 2020

Prognostic significance of regulatory T cells in tumor

1 reference

12 December 2020

Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver

1 reference

12 December 2020

Increase of regulatory T cells in the peripheral blood of cancer patients.

1 reference

12 December 2020

Increased soluble CD95 (sFas/CD95) serum level correlates with poor prognosis in melanoma patients

1 reference

12 December 2020

10.1038/NRCLINONC.2016.144

Identifiers

DOI

1 reference

PubMed ID

27644321

Dimensions Publication ID

8 September 2017

0 references

1 reference

PubMed ID

27644321